FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Abattis Bioceuticals Corp

  • Home
  •  | 
  • Tag Archives: "Abattis Bioceuticals Corp"

Abattis Bioceuticals Provides Phase 1 Update on Research and Development for Nanoemulsification and Liposomal Platforms of Cannabinoid-Rich Hemp Oil

Abattis Bioceuticals Provides Phase 1 Update on Research and Development for Nanoemulsification and Liposomal Platforms of Cannabinoid-Rich Hemp Oil
Phase 1 of the study was a comparison of studies of transmucosal (stomach lining) vs sublingual (under the tongue) absorption of cannabinoids. The focus of this study is to confirm that sublingual absorption is indeed superior in terms of providing a higher percentage of successful cannabinoid reception into the bloodstream, providing much faster medical benefits through increasingly efficient absorption. Abattis is currently in the running to be one of the first bioceuticals companies to publish public research on sublingual and transmucosal absorption of cannabinoids.
Read more

Emerald Health to acquire rest of Northern Vine

Emerald Health to acquire rest of Northern Vine
Emerald Health Therapeutics Inc. has signed a definitive agreement to acquire the remaining shares of Northern Vine Canada Inc., owned by Abattis Bioceuticals Corp., for $2-million in cash and $4-million in shares of Emerald stock. This transaction increases Emerald's ownership of Northern Vine from 65% to 100%. Northern Vine is a Licensed Dealer (LD) under the provisions of the Canadian Controlled Drugs and Substances Act.
Read more